WACKER CHEMIE AG: GREENSHOE OPTION FULLY EXERCISED
ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
Munich, April 10, 2006 - In connection with the IPO of Wacker Chemie AG, the selling shareholders Blue Elephant Holding GmbH and Wacker Chemie AG had granted Morgan Stanley Bank AG (for account of the syndicate banks) the option to purchase up to 15% of shares of the original transaction volume, i.e. up to 1,955,723 additional shares in the company, from Blue Elephant Holding GmbH (up to 1,178,770 additional shares) and Wacker Chemie AG (up to 776,953 additional shares) at the offer price of EUR 80.00 (Greenshoe-Option). After an additional 1,955,723 shares were allocated over the weekend on the basis of this option, Morgan Stanley Bank AG today exercised the Greenshoe Option in full and the syndicate banks purchased 1,178,770 additional shares from Blue Elephant Holding GmbH and 776,973 additional shares from Wacker Chemie AG. Wacker Chemie AGs aggregate gross proceeds raised therefrom amount to approximately EUR 62 million.
The stabilization period terminated with the exercise of the Greenshoe-Option. During the stabilization period no stabilization measures were undertaken by Morgan Stanley Bank AG as stabilization manager.
The total number of shares sold in the course of the IPO of Wacker Chemie AG therefore amounts to 14,993,873 shares (including 1,955,723 Greenshoe shares) with an aggregate value of approximately EUR 1.2 billion. Taking into account the full exercise of the Greenshoe-Option, the free float of the shares is now approximately 28.75 percent of the share capital of Wacker Chemie AG.
This press release does not constitute an offer to sell or the solicitation of an offer to purchase the shares or other securities of Wacker Chemie AG. The offer is made exclusively through and on the basis of the prospectus, as published, and supplement No. 1 thereto. Investors should not make an investment decision with respect to the shares or any other securities of Wacker Chemie AG except on the basis of the information contained in the prospectus and supplement No. 1 thereto. Free copies of this material are available to investors from Wacker Chemie AG.
This press release is not an offer of securities for sale in the United States of America. Securities may not be offered or sold in the United States of America absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. Any public offering of securities to be made in the United States of America will be made by means of a prospectus that may be obtained from Wacker Chemie AG and that will contain detailed information about the company and management, as well as financial statements. The information contained in this press release is not for publication or distribution in the United States of America, Canada, Australia or Japan and does not constitute an offer of securities for sale in the United States of America, Canada, Australia or Japan.
This press release is directed only at persons outside the U.K. (the "relevant persons"). Each solicitation of an offer, each offer and each agreement to subscribe for, to purchase or to otherwise acquire the securities is directed only at relevant persons and at certain other persons or will be entered into only with relevant persons or certain other persons. Persons who are not relevant persons should not act on the basis of or rely on the information contained therein.
end of announcement euro adhoc 10.04.2006 20:25:41
Further inquiry note:
Christof Bachmair
+49 (0)89 6279 1830
christof.bachmair@wacker.com
Branche: Chemicals
ISIN: DE000WCH8881
WKN: WCH888
Index: CDAX
Börsen: Frankfurter Wertpapierbörse / official dealing/prime standard
Börse Berlin-Bremen / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Bayerische Börse / free trade